Skip to main content
. Author manuscript; available in PMC: 2021 Sep 10.
Published in final edited form as: Cancer Causes Control. 2020 Feb 28;31(4):365–375. doi: 10.1007/s10552-020-01287-z

Table 3.

Impact of genital high-risk HPV and human herpesvirus detection on cervical squamous intraepithelial lesions (SIL) in HIV-infected women.

Genital
hrHPV
Genital
HHV
SIL-Negative
No. (%)
SIL-Positive
No. (%)
Odds Ratio
(95% CI)
p-valueb
Any HHV
95 (86.4) 15 (13.6) Reference
+ 41 (51.9) 38 (48.1) 5.87 (2.91-11.83) <.0001
+ 18 (75.0) 6 (25.0) 2.11 (0.72-6.17) .14
+ + 9 (39.1) 14 (60.9) 9.85 (3.63-26.76) <.0001
+ 41 (51.9) 38 (48.1) Reference
+ + 9 (39.1) 14 (60.9) 1.68 (0.65-4.33)a .20
EBV
100 (84.7) 18 (15.3) Reference
+ 46 (52.3) 42 (47.7) 5.07 (2.64-9.75) <.0001
+ 13 (81.3) 3 (18.7) 1.28 (0.33-4.96) .48
+ + 4 (28.6) 10 (71.4) 13.89 (3.94-49.15) <.0001
+ 46 (52.3) 42 (47.7) Reference
+ + 4 (28.6) 10 (71.4) 2.74 (0.80-9.40)a .09
a

Odds ratio of SIL in women with both hrHPV and HHV (top of table) or EBV (bottom of table) compared to women with hrHPV but no HHV or EBV, respectively.

b

Fisher’s Exact Test p-value is presented.

Abbreviations: hrHPV, high-risk human papillomavirus. HHV, human herpesvirus. SIL, squamous intraepithelial lesion. CI, confidence interval. EBV, Epstein-Barr virus.